Acute neurologic complications in children with systemic cancer

Journal of Child Neurology

Volumn 15, Issue 11, 2000, Pages 705-716

  Antunes, N L ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; CHILD; CHILDHOOD CANCER; CLINICAL FEATURE; DIAGNOSTIC APPROACH ROUTE; EVALUATION; HUMAN; NEUROLOGICAL COMPLICATION; PRIORITY JOURNAL; REVIEW; SYMPTOM;

EID: 0034527320     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307380001501101     Document Type: Review

References (195)

1. Neurological consultations in children with cancer
2. The spectrum of neurologic disease in patients with systemic cancer
3. Headache in children with cancer, abstract
4. Postdural puncture headache in pediatric oncology patients
5. The incidence of postdural puncture headache in children
6. Most doctors are unaware of features of headache after lumbar puncture, letter
7. MRI changes in intracranial hypotension
8. Subdural hematoma after lumbar puncture: Two case reports and review of the literature
9. Adverse effects of intrathecal methotrexate in children with acute leukemia in remission
10. Methotrexate meningitis, letter
11. Contraindication to lumbar puncture as defined by computed cranial tomography
12. Cerebral herniation during bacterial meningitis in children
13. Cerebellar coning and uncal herniation in childhood acute leukaemia
14. Changes in cell and protein content of cerebrospinal fluid in children with acute lymphoblastic leukaemia after allogeneic bone marrow transplantation
15. Meningeal fluid granulocytosis after cytarabine, letter
16. Is caffeine withdrawal the mechanism of postoperative headache?
17. Caffeine intakes from a biracial population: The Bogalusa Heart Study
18. 3 receptor antagonists in radiotherapy-induced nausea and vomiting: A quantitative systematic review
19. Intracranial metastases in pediatric solid tumors, abstract
20. Brain abscesses in children with cancer
21. Brain abscess following marrow transplantation: Experience at the Fred Hutchinson Cancer Research Center, 1984-92
22. Trends in the management of bacterial brain abscess: A review of 102 cases over 17 years
23. Cerebral abscess in children
24. Brain abscess: A study of 45 consecutive cases
25. Effect of dexamethasone on various stages of experimental brain abscess
26. Should prophylactic anticonvulsants be administered to patients with newly-diagnosed cerebral metastases? A retrospective analysis
27. Infectious complications in the pediatric cancer patient
28. Central nervous system infection in the chronically immunosuppressed
29. MRI of Lysteria rhombencephalitis
30. MRI in varicella-zoster leukoencephalitis in the immunocompromised host
31. Herpes varicella zoster encephalitis in immunocompromised patients
32. Fatal herpesvirus 6 encephalitis after unrelated bone marrow transplant
33. MRI of herpes simplex encephalitis
34. Cytomegalovirus encephalitis
35. Images in neurology: Mass effect in progressive multifocal leukoencephalopathy
36. Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component
37. Chronic subdural hematoma in childhood acute leukemia
38. Intracranial haematomas following bone marrow transplantation
39. Subdural hygromas after bone marrow transplantation: Results of a prospective study
40. Seizures in childhood lymphoblastic leukaemia patients
41. Prognosis and treatment of seizures in children with acute lymphoblastic leukemia
42. Seizures after bone marrow transplant, abstract
43. Neurotoxicity of carbapenem antibacterials
44. Fluconazole-induced symptomatic phenytoin toxicity
45. Ciprofloxacilin-phenytoin interaction, letter
46. Phenytoin toxicity and co-trimoxazole
47. Dose-dependent effect of cimetidine on phenytoin kinetics
48. Preirradiation paclitaxel in glioblastoma multiforme: Efficacy, pharmacology, and drug interactions. New approaches to brain tumor therapy central nervous system consortium
49. Evaluation of cyclosporin-phenytoin interaction with observations on cyclosporin metabolites
50. Antiepileptic drug hypersensitivity syndrome
51. Gabapentin for seizure control in organ transplant recipients, letter
52. Treatment of concomitant illnesses in patients receiving anticonvulsants: Drug interactions of clinical significance
53. A reversible posterior leukoencephalopathy syndrome
54. Cyclosporine neurotoxicity
55. Cyclosporine induces apoptosis and selective oligodendrocyte death in cortical cultures
56. Parietal occipital edema in hypertensive encephalopathy: A pathogenic mechanism
57. Cyclosporine neurotoxicity and its relationship to hypertensive encephalopathy: CT and MRI findings
58. Posterior leukoencephalopathy may not be reversible
59. Posterior leukoencephalopathy without severe hypertension: Utility of diffusion-weighted MRI
60. Immunosuppression-induced leukoencephalopathy from tacrolimus (FK506)
61. Cyclosporin A acute encephalopathy and seizure syndrome in childhood: Clinical features and risk of seizure recurrence
62. Clonazepam prophylaxis and busulfan-related myoclonic epilepsy in autografted acute leukemia patients
63. Incidence of prophylactic anticonvulsant therapy on high-dose busulfan kinetics
64. Reversible encephalopathy and seizures as a result of conventional vincristine administration
65. Seizures associated with vincristine sulfate therapy
66. Ifosfamide-induced nonconvulsive status epilepticus
67. Epileptic seizures associated with cisplatin administration
68. Cytarabine and neurologic toxicity
69. Acute mental status changes in children with systemic cancer
70. Jaw and other orofacial pain in patients receiving vincristine for the treatment of cancer
71. Muscle cramps associated with vincristine therapy
72. Clinical toxicity of cytokines used as haemopoietic growth factors
73. Back pain in children: Symptoms which should be taken seriously
74. Back pain in children and adolescents
75. Malignancies in children that initially present with rheumatic complaints
76. Pediatric spinal epidural metastases
77. Chemotherapy as the initial treatment of spinal cord compression due to disseminated neuroblastoma
78. The treatment of neuroblastoma with intraspinal extension with chemotherapy followed by surgical removal of residual disease
79. Incidence, presentation and outcome of spinal cord disease in children with systemic cancer
80. Presentation of steroid psychoses
81. Corticosteroids in cancer: Neuropsychiatric complications
82. Paradoxical reactions in children associated with midazolam use during endoscopy
83. Central nervous system reactions to histamine-2 receptor blockers
84. Negative myoclonus during valproate-related stupor: Neurophysiologic evidence of a cortical non-epileptic origin
85. Should promethazine in liquid form be available without prescription?
86. Diphenhydramine-induced toxic psychosis
87. Ciprofloxacin and delirium
88. Acyclovir- and gancyclovir-induced neurotoxicity
89. Drug-induced psychoses
90. Hallucinations and ifosfamide-induced neurotoxicity
91. Acute neurologic dysfunction associated with high-dose chemotherapy and autologous bone marrow rescue for primary malignant brain tumors
92. Methylene blue and the neurotoxic mechanisms of ifosfamide encephalopathy
93. Hallucinations and ifosfamide-induced neurotoxicity
94. Cerebral atrophy in an infant following treatment with ifosfamide
95. Reversal of amphotericin-B-related encephalopathy
96. Reversal of encephalopathy during treatment with amphotericin-B
97. Amphotericin B-associated leukoencephalopathy
98. The encephalopathy associated with septic illness
99. Infection impaired consciousness as the initial symptom: Clinical and pathophysiologic aspects of septic encephalopathy
100. Iatrogenic Wernicke's encephalopathy in allogeneic bone marrow transplantation: A study of eight cases
101. Wernicke encephalopathy -- A preventable cause of death: Report of 2 children with malignant disease
102. Wernicke's encephalopathy in a child with prolonged vomiting
103. Syndrome of idiopathic hyperammonemia after high-dose chemotherapy: Review of nine cases
104. Hyperammonemic encephalopathy after chemotherapy: Survival after treatment with sodium benzoate and sodium phenylacetate
105. Complete response in severe thrombotic microangiopathy post bone marrow transplant (BMT-TM) after multiple plasmapheresis
106. Thrombotic microangiopathies associated with drugs and bone marrow transplant
107. Transient cerebral dysfunction secondary to high-dose methotrexate
108. Transient encephalopathy following high-dose methotrexate treatment in childhood acute lymphoblastic leukemia
109. Cerebrovascular accidents in children with cancer
110. Dural sinus thrombosis in children with acute lymphoblastic leukemia
111. Cerebrovascular complications of L-asparaginase therapy
112. Thromboembolic complications associated with L-asparaginase therapy: Etiologic role of low antithrombin III and plasminogen levels and therapeutic correction by fresh frozen plasma
113. Thrombotic events are not exclusive to the remission induction period in patients with acute lymphoblastic leukemia: A report of two cases of cerebral sinus thrombosis
114. Superior sagittal sinus thrombosis complicating maintenance treatment for acute lymphoblastic leukemia
115. Dural sinus thrombosis in children with cancer
116. Reversible MRI lesions due to pegaspargase treatment of non-Hodgkin lymphoma
117. Cerebral venous thrombosis: Developments in imaging and treatment
118. Physiologic mechanisms underlying the delayed delta sign
119. Superior sagittal sinus thrombosis
120. High-dose heparin plus warfarin administration in non-traumatic dural sinuses thrombosis: A clinical and neuroradiological study
121. Non-Hodgkin's lymphoma as a new cause of non-thrombotic superior sagittal sinus occlusion
122. Childhood acute promyelocytic leukemia: A rare variant of nonlymphoid leukemia with distinctive clinical and biologic features
123. Acute promyelocytic leukemia in children
124. Neurologic complications of leukemia
125. Chronic subdural hematoma in childhood acute leukemia
126. Unexpected high incidence of intracranial subdural haematoma during intensive chemotherapy for acute myeloid leukaemia with a monoblastic component
127. Neurologic complications of autologous and allogeneic bone marrow transplantation in patients with leukemia: A comparative study
128. Intracranial haematomas following bone marrow transplantation
129. Episodic neurologic dysfunction in patients with Hodgkin's disease
130. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma
131. Transient cerebral dysfunction after treatment with moderately high-dose methotrexate, letter
132. Homocysteine and vascular disease
133. Elevation of homocysteine and excitatory amino acid neurotransmitters in the CSF of children who receive methotrexate for the treatment of cancer
134. Characterization of the stress-inducing effects of homocysteine
135. High dose systemic methotrexate-associated acute neurologic dysfunction
136. "Complicated migraine-like episodes" in children following cranial irradiation and chemotherapy
137. Spinal subdural hematomas complicating lumbar puncture
138. Spinal subdural hematoma in a leukemic child
139. Spinal epidural lipomatosis as a complication of prolonged corticosteroid therapy
140. Bacterial infections of the CNS in neutropenic patients
141. Radicular vessels are the most probable source of needle-induced blood in lumbar puncture: Significance for the thrombocytopenic cancer patient
142. Spinal subarachnoid hematoma complicating lumbar puncture: Diagnosis and management
143. Spontaneous spinal epidural haematoma in a youngster
144. Spontaneous spinal epidural hematoma in the young
145. Outcome and complications of epidural analgesia in patients with chronic cancer pain
146. Spinal epidural abscess complicating vertebral osteomyelitis: An insidious cause of deteriorating spinal cord function
147. Spinal epidural abscess due to Aspergillus infection of the vertebrae: Report of 3 cases
148. Spinal epidural abscess: Treatment options
149. Spinal epidural abscess: Evaluation of factors influencing outcome
150. Spinal cord compression by epidural lipomatosis in juvenile rheumatoid arthritis
151. Long-term gross motor performance following treatment for acute lymphoblastic leukemia
152. Excessive spinal cord toxicity from intensive central nervous system-directed therapies
153. Acute myelopathy after chemotherapy for central nervous system acute lymphoblastic leukemia: Correlation with cerebrospinal fluid myelin basic therapy
154. Progressive ascending paralysis following administration of intrathecal and intravenous cytosine arabinoside: A pediatric oncology group study
155. Acute ascending myelitis and encephalopathy after intrathecal cytosine arabinoside and methotrexate in an adolescent boy with acute lymphoblastic leukemia
156. Anterior lumbosacral radiculopathy after intrathecal methotrexate treatment
157. Radiation myelitis following craniospinal irradiation with concurrent actinomycin-D therapy
158. Subacute radiation myelopathy in a 12-year-old boy
159. Neuromuscular complications of bone marrow transplantation
160. Polyneuropathy complicating bone marrow and solid organ transplantation
161. Guillain-Barré syndrome following allogeneic bone marrow transplantation
162. Neuromuscular complications of sepsis in children
163. Meralgia paresthetica in children
164. Management of subclavian-axillary vein thrombosis: A review
165. Catheter-related thrombosis
166. Electric shock-like sensations in 42 cancer patients: Clinical characteristics and distinct etiologies
167. Development of Lhermitte's sign after bone marrow transplantation
168. Anti-cancer cisplatin-related Lhermitte's sign
169. Numb chin syndrome in cancer patients: Etiology, response to treatment, and diagnostic significance
170. Mental neuropathy (numb chin syndrome): A harbinger of tumor progression or relapse
171. Optic atrophy following prophylactic chemotherapy and cranial radiation for acute lymphoblastic leukemia
172. Blindness during remission in two patients with acute lymphoblastic leukemia -- A possible complication of multimodal therapy
173. Carotid-cavernous sinus thrombosis caused by Aspergillus fumigatus: Magnetic resonance imaging with pathologic correlation -- A case report
174. Transient Horner's syndrome after lumbar epidural anesthesia
175. Neuro-ophthalmology of pupillary function-practical guidelines
176. Ocular complications of vincristine therapy
177. Opsoclonus and occult neuroblastoma
178. Parkinsonism during cyclosporine treatment
179. Focal dystonia after chemotherapy: A case series
180. Clinical spectrum of secondary parkinsonism in childhood: A reversible disorder
181. Pathophysiology and treatment of opioid-related myoclonus in cancer patients
182. The serotonin syndrome: Implicated drugs, pathophysiology and management
183. Carbamazepine-induced choreoathetoid dyskinesias, letter
184. Phenytoin-induced choreoathetosis, letter
185. Choreoathetotic movements: A possible side effect of gabapentin
186. Reversible parkinsonism in a child after bone marrow transplantation and lipid-based amphotericin B therapy
187. Cytosine arabinoside and amphotericin B-induced parkinsonism
188. Encephalopathy with parkinsonian features in children following bone marrow transplantations and high-dose amphotericin B
189. Recognizing syncope: Pitfalls and surprises
190. Transient loss of consciousness: The value of the history for distinguishing seizure from syncope
191. Vinca alkaloid-induced cardiovascular autonomic neuropathy
192. Glossopharyngeal neuralgia and syncope secondary to neck malignancy
193. Psychiatric symptomatology in adolescents with cancer